Suppressive effect of zinc ion on iNOS expression induced by interferon-γ or tumor necrosis factor-α in murine keratinocytes

Journal of Dermatological Science

Volumn 23, Issue 1, 2000, Pages 27-35

  Yamaoka, Junichi ^a   Kume, Toshiaki ^a   Akaike, Akinori ^a   Miyachi, Yoshiki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Keratinocytes; Nitric oxide; Nitric oxide synthase; Zinc ion

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; ZINC ION;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; GENE EXPRESSION; INTERFERON-GAMMA, RECOMBINANT; KERATINOCYTES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; ZINC;

EID: 0033952206     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(99)00062-6     Document Type: Article

References (63)

1. Aggarwal BB, Mehta K. Determination and regulation of nitric oxide production from macrophages by lipopolysaccharides, cytokines and retinoids. Methods Enzymol 1996;269:166-71.
2. Crow JB, Beckman JS. The role of peroxynitrite in nitric oxide-mediated toxicity. In: Koprowski H, Maeda H, editors. The Role of Nitric Oxide in Physiology and Pathophysiology. Berlin: Springer, 1995:57-73.
3. Beckman JS, Beckman TVV, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
4. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance [review]. FEBS Lett 1995;369:131-5.
5. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-63.
6. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.
7. Corbett JA, MacDaniel ML. Intraislet release of interleukin-1 inhibits β-cell function by inducing β-cell expression of inducible nitric oxide synthase. J Exp Med 1995;181:559-68.
8. Reynolds PD, Middleton SJ, Huter JO, Facer P, Biship A, Evans T, Polak JM. High expression of iNOS in colon mucosa in ulcerative colitis. Gastroenterology 1995;108:A903.
9. Ungureanu-Longrois D, Balligand JL, Simmons WW, Okada I, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TVV. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circ Res 1995;77:494-502.
10. Mikami S, Kawashima S, Kanazawa K, Hirata K, Katayama Y, Hotta H, Hayashi Y, Ito H, Yokoyama M. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by Coxsackie virus B3. Biochem Biophys Res Commun 1996;220:983-9.
11. Weinberg JB, Granger DL, Pisetsky DL, Seldin MF, Misukonis MA, Mason SN, Pippen AN, Ruiz P, Wood ER, Gilkeson GS. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune diseases: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethy-l-arginine. J Exp Med 1994;179:651-60.
12. Weller R. Nitric oxide - a newly discovered chemical transmitter in human skin. Br J Dermatol 1997;137:665-72.
13. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide and its implications in skin homeostasis and disease - a review. Arch Dermatol Res 1998;290:643-51.
14. Heck DE, Laskin DL, Gardner CR, Laskin JD. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 1992;267:21277-80.
15. Prasad AS. Discovery of human zinc deficiency and studies in an experimental human model. Am J Clin Nutr 1991;53:403-12.
16. Vallee BL, Auld DS. Zinc: biological functions and coordination motifs. Acc Chem Res 1993;26:543-51.
17. Guéniche A, Viac J, Lizard G, Charveron M, Schmit D. Protective effect of zinc on keratinocyte activation markers induced by interferon or nickel. Acta Derm Venereol 1995;75:19-23.
18. Sainte-Marie I, Jumbou O, Tenaud I, Dreno B. Comparative study of the in vitro inflammatory activity of three nickel salts on keratinocytes. Acta Derm Venereol 1998;78:169-72.
19. Michäelsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol 1977;113:31-6.
20. Toyoda M, Morohashi M. An overview of topical antibiotics for acne treatment. Dermatology 1998;196:130-4.
21. Schachner L, Eaglstein W, Kittles C, Mertz P. Topical erythromycin and zinc therapy for acne. J Am Acad Dermatol 1990;22:253-60.
22. Habbema L, Koopmans B, Menke HE, Doornweerd S, De-Boulle K. A 4% erythromycin and zinc combination (Zineryt) versus 2% eythromycin (Eryderm) in acne vulgaris: a randomized, double blind comparative study. Br J Dermatol 1989;121:497-502.
23. Dreno B, Amblard P, Agache P, Sirot S, Litoux P. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol 1989;69:541-3.
24. Lutz G, Kreysel HW. Selektive Veranderungen lymphozytarer Differenzierungsantigene im peripheren Blut bei Patienten mit Alopecia areata unter oraler Zinktherapie. Z Hautkr 1990;65:132.
25. Leyh F. Zink - ein neues Therapieprinzip in der Dermatologie? Z Hautkr 1987;62:1064.
26. Simkin PA. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976;2:539-42.
27. Black MM, Gawkrodger DJ, Seymour CA, Weismann K. Metabolic and nutritional disorders. In: Rook A, Wilkinson DS, Ebling FJG, editors. Textbook of Dermatology, 6th edn. London: Blackwell, 1998:2577-677.
28. Tasaki M, Hanada K, Hashimoto I. Analyses of serum copper and zinc levels and copper/zinc ratios in skin diseases. J Dermatol 1993;20:21-4.
29. Cui L, Takagi Y, Wasa M, Iiboshi Y, Khan J, Nezu R. Induction of nitric oxide synthase in rat intestine by interleukin-1 may explain diarrhea associated with zinc deficiency. J Nutr 1997;127:1729-36.
30. Yuspa S, Hawley-Nelson P, Koehler B, Stanley JR. A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res 1980;40:4694-703.
31. Nims RW, Cook JC, Krishna MC, Christodoulou D, Poore CMB, Miles AM, Grisham MB, Wink DA. Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 1996;268:93-105.
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
33. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ. Keratinocytes as initiators of inflammation. Lancet 1991;337:211-4.
34. Kupper TS, Groves RW. The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol 1995;105:62S-6S.
35. Kupper TS. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 1990;94:146S-50S.
36. Piguet PF, Grau GE, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 1991;173:673-9.
37. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 1992;89:1398-402.
38. Kondo S, Sauder DN. Epidermal cytokines in allergic contact dermatitis. J Am Acad Dermatol 1995;33:786-800.
39. Seery JP, Carroll JM, Cattell V, Watt FM. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med 1997;186:1451-9.
40. Piguet PF, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of acute phase of graft-vs-host disease. J Exp Med 1987;166:1280-9.
41. Ferrara JL, Cooke KR, Pan L, Krenger W. The immunopathophysiology of acute graft-versus-host disease. Stem Cells 1996;14:473-89.
42. Haanen JBAG, De Waal Malefijt R, Res PCM, Kraakman EM, Ottenhoff THM, De Veries RRP, Spits H. Selection of a human T helper type-1 like T cell subset by micobacteria. J Exp Med 1991;174:583-92.
43. Yssel H, Shanafelt MC, Soderberg C, Schneider PV, Anzola J, Peltz G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 1991;174:593-601.
44. Kemény L, Michel G, Dobozy A, Ruzicka T. Cytokine system as potential target for antipsoriatic therapy. Exp Dermatol 1994;3:1-8.
45. Schlaak JF, Baslau M, Jochum W, Hermann E, Girndt M, Gallati H, Hermann K, zum Büschenfeld M, Fleischer B. T cells involved in psoriasis vulgaris belongs to the Th1 subset. J Invest Dermatol 1994;102:145-9.
46. Werfel T, Morita A, Greve M, Renz H, Wahn U, Krutmann J, Kapp A. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 1996;107:871-6.
47. Thepe T, Langeveld-Wildschut EG, Bihari IC, van Wichsen CF, van Reijsen FC, Mudde GC, Bruijnzeel-Koomen CAFM. Bi-phasic response against aeroantigen in atopic dermatitis showing a switch from initial Th2 response into a Th1 response in situ. An immuno-cytochemical study. J Allergy Clin Immunol 1996;97:828-37.
48. Köck A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luget TA. Human keratinocytes are a source for tumor necrosis factor: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990;172:1609-14.
49. Kupper TS, Chua AO, Flood P, McGuire J, Gubler U. Interleukin-1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 1987;80:430-6.
50. Arnaud J, Beani JC, Favier AE, Amblard P. Zinc status in patients with telogen defluvium. Acta Derm Venereol 1995;75:248-9.
51. Mori H, Matsumoto Y, Tamada Y, Ohashi M. Apoptotic cell death in formation of vesicular skin lesions in patients with acquired zinc deficiency. J Cutan Pathol 1996;23:359-63.
52. Mori H, Matsumoto Y, Ohashi M, Tamada Y. Correlation of apoptosis and changes in skin lesions of zinc deficient mice. Jpn J Dermatol 1996;106:15-20 in Japanese.
53. Melková Z, Lee SB, Rodriguez D, Esteban M. Bcl-2 prevents nitric oxide-mediated apoptosis and poly (ADP-ribose) polymerase cleavage. FEBS Lett 1997;403:273-8.
54. Dreno B, Trossaert M, Boiteau HL, Litou P. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol 1992;72(4):250-2.
55. Shaheen AA, El Fattah AA. Effect of dietary zinc on lipid peroxidation, glutathione, protein thiols levels and superoxide dismutase activity in rat tissues. Int J Biochem Cell Biol 1995;27:89-95.
56. Mullin CH, Frings G, Abel J, Kind PP, Goer G. Specific induction of Metallothionein in hairless mouse skin by zinc and dexamethasone. J Invest Dermatol 1989;89:164-6.
57. Bettger WJ, O'Dell BL. A critical physiological role of zinc in the structure and function of biomembranes. Life Sci 1981;28(13):1425-38.
58. Tian L, Lawrence DA. Metal-induced modulation of nitric oxide production in vitro by murine macrophages: lead, nickel, and cobalt utilize different mechanisms. Toxicol Appl Pharmacol 1996;141:540-7.
59. 2+ inhibits nitric oxide formation in response to lipopolysaccharide: Implication in its anti-inflammatory activity. Eur J Pharmacol 1998;341:265-72.
60. 2+ Ion. Biochemistry 1995;34:15091-5.
61. Crane BR, Arvai AS, Ghosh DK, Wu C, Getzoff ED, Steuer DJ, Tainer DJ. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998;279:2121-6.
62. Raman CS, Li H, Martásek P, Král V, Masters BSS, Poulos TL. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 1998;95:939-50.
63. Bettger WJ. Zinc and selenium, site-specific versus general antioxidation. Can J Physiosol Pharmacol 1993;71:721-4.